U.S. Downstream Processing Market Size, Share & Trends Analysis Report By Product (Chromatography Systems, Filters), By Technique (Cell Disruption, Formulation), By Application (Antibiotic Production), And Segment) - Industry Analysis, Size, Share, Growth, Trends, and Forecast 2024-2033

The U.S. downstream processing market size was estimated at USD 12.90 billion in 2023 and is expected to be worth around USD 49.53 billion by 2033, poised to grow at a compound annual growth rate (CAGR) of 14.4% during the forecast period 2024 to 2033.

U.S. Downstream Processing Market Key Takeaways

• The chromatography systems segment accounted for the largest revenue share of 41.21% in 2023.
• The filters segment is expected to register the fastest CAGR from 2024 to 2033.
• The purification by chromatography segment held the largest revenue share of 41.16% in 2023.
• Solid-liquid separation is expected to witness the fastest CAGR during the forecast period.
• The antibiotic production segment generated the largest revenue share of 30.55% in 2023.
• Antibodies production is expected to grow at the fastest CAGR during the forecast period.

U.S. Downstream Processing Market Growth Factors

Major players are focused on streamlining the downstream process and reducing the overall cost of the procedure and the product. Downstream technology is increasingly used in laboratory and industrial-scale applications owing to the growing demand for biologics, which is expected to boost market growth.

The market in the U.S. is expected to grow significantly shortly, owing to the increasing adoption of bioprocessing and biotechnology techniques within the country. The commercial production and sale of products obtained from or used in new biotechnology techniques is relatively recent. Some of the notable products include Amgen's Blincyto and Novartis's Zarxio, the first FDA-approved biosimilar in the U.S. There has been a substantial rise in the sales of biotechnology products within the country owing to recent advancements, and it is expected that there will be a 10-fold increase in the sales in the coming decade.

The global downstream processing market witnessed the U.S. accounting for over 32% of its revenue share in 2023. Thanks to the biotechnology sector's continuous innovation, the market is expected to experience substantial growth opportunities throughout the forecast period. Moreover, the biopharmaceutical sector is considered the most R&D-intensive in the U.S. Biopharmaceuticals development is recognized as a high impact rendering driver to influence the adoption of downstream processing technologies in the coming years. Manufacturing entities such as Corning Life Sciences are constantly developing new technologies and products to reduce the intricacy of their bioproduction processes. Such initiatives are opportunistic for market growth.

U.S. Downstream Processing Market Report Scope

U.S. Downstream Processing Market By Product Insights

The chromatography systems segment accounted for the largest revenue share of 41.21% in 2023. Chromatography systems include a wide range of products such as chromatography membranes, resins, cleaning-in-place solutions, buffers, and compatible hardware, including single-use systems, multi-use systems, and columns. These products are assembled to form a system used during the DSP purification step. Major market players offer safe, integrated chromatography solutions that work efficiently during all the steps, from process development to production scale. In recent years, key players have developed technologically efficient chromatography systems to address the growing need of pharmaceutical manufacturers. For instance, single-use chromatography represents one of the most significant inventions in the biopharmaceutical industry.

The filters segment is expected to register the fastest CAGR from 2024 to 2033. Harvesting of biological products from large cultures largely depends on filtration, as biomolecules are extremely sensitive to heat and chemical treatments. This eliminates the use of alternative methods for biopharmaceutical filtration. Major types of filters used during a DSP include depth filters, absolute filters, rotary drum vacuum filters, and membrane filters. Filter manufacturers have developed advanced filters with high capacity and performance owing to increased demand for viral clearance and cell densities & titers. Filtration is particularly essential in viral safety as a virus can considerably impact an entire process.

U.S. Downstream Processing Market By Technique Insights

The purification by chromatography segment held the largest revenue share of 41.16% in 2023. Chromatography is an essential step during the isolation and purification of most of the high-value products. The technique is useful, especially during the DSP of proteins. Chromatography is a major technique that can be employed at all levels of DSP from the first capture to the final step. The most used chromatographic techniques during a DSP include ion exchange chromatography, hydrophobic interaction chromatography, affinity chromatography, and gel filtration chromatography.

Solid-liquid separation is expected to witness the fastest CAGR during the forecast period. Solid-liquid separation refers to the initial stages of product recovery in which whole cells and insoluble ingredients are separated from culture broth that contains the desired products. Major techniques used for solid-liquid separation include flotation, flocculation, filtration, centrifugation, or a combination of these. However, on a production scale, large centrifuges and micro filters are used for separation. The microfiltration technique is the preferred method for the separation of cell debris from the medium. In microfiltration, the mixture is allowed to pass through membranes with pores ranging from 0.1 to 0.8 microns in diameter, depending upon the type of cells present in the process medium.

U.S. Downstream Processing Market By Application Insights

The antibiotic production segment generated the largest revenue share of 30.55% in 2023. Antibiotics are used to treat several conditions, from cancers to infectious diseases. β-lactam antibiotics, especially cephalosporin and penicillin, are among the most commercialized antibiotics worldwide. Natural cephalosporin and penicillin are manufactured on an industrial scale through bioprocessing techniques and are harvested through downstream processing. With the growing incidence of antibiotic resistance, the demand for developing antibodies against resistant strains has increased. This, in turn, is likely to drive the demand for bioprocessing technologies for antibody production at an industrial scale and will boost market growth during the forecast period.

Antibodies production is expected to grow at the fastest CAGR during the forecast period. Monoclonal antibodies are used for various clinical indications such as cancers, inflammatory disorders, and infectious diseases. These products are one of the most predominant modalities the biopharmaceutical industry offers today. This can be attributed to establishing robust manufacturing platforms that produce high titers for monoclonal antibodies in mammalian cell cultures. In addition, the evolution of certain new methods in the bioprocessing of antibodies has further propelled the market growth as they have led to an evolution in process platform approaches.

U.S. Downstream Processing Market Recent Developments

• In January 2023, Sartorious entered a strategic collaboration with RoosterBio Inc. for enhancing its exosome-based therapies’ downstream purification processes.
• In March 2022, Rentschler Biopharma along with Vetter unveiled the launch of Xpert Alliance. The alliance is purposed to support the companies to deliver advanced solutions to customers' challenging demands in the field of biopharmaceuticals.
• In February 2022, Sartorius announced the acquisition of Novasep's chromatography business. The portfolio comprises chromatography systems developed especially for smaller biomolecules including peptides, insulin, and oligonucleotides, as well as new technologies for continuous production of biologics.

Key U.S. Downstream Processing Company Insights

Key U.S. downstream processing companies include Danaher Corporation, GE Healthcare, and Thermo Fisher Scientific Inc. among others. Companies are expanding their global footprint by establishing collaborations, partnerships, and acquisitions to tap in new markets and countries. Collaborations with healthcare providers and research institutions, such as the Mayo Clinic and academic medical centers, are opportunistic to access expertise and assess their technologies.

U.S. Downstream Processing Market Top Key Companies:

• Merck KGaA
• Sartorius Stedim Biotech S.A
• GE Healthcare
• Thermo Fisher Scientific Inc.
• Danaher Corporation
• Repligen
• 3M Company
• Boehringer Ingelheim International GmbH
• Corning Corporation
• Lonza Group Ltd
• Dover Corporation
• Ashai Kasei
• Ferner PLC
• Eppendorf AG

U.S. Downstream Processing Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Nova one advisor, Inc. has segmented the U.S. Downstream Processing market.

By Product 

• Chromatography Systems
• Filters
• Evaporators
• Centrifuges
• Dryers
• Others

By Technique 

• Cell Disruption
• Solid-liquid Separation
  • Filtration
  • Centrifugation
• Concentration
  • Evaporation
  • Membrane Filtration
• Purification By Chromatography
• Formulation 

By Application 

• Antibiotic Production
• Hormone Production
• Antibodies Production
• Enzyme Production
• Vaccine Production